Amit Bhalla
Citigroup
Recent Quotes
"TMO's positive 2012 financial trajectory should continue into 2013."
—
Amit Bhalla, Citigroup
(2/13/13)
more >
"EW should see greater benefits from a ramp-up in TAVI adoption."
—
Amit Bhalla, Citigroup
(12/4/12)
more >
"We maintain our Buy rating on EW."
—
Amit Bhalla, Citigroup
(4/19/12)
more >
"EW's Sapien/TAVI is one of the most significant new products in medtech."
—
Amit Bhalla, Citigroup
(4/12/12)
more >
Due to permission requirements, not all quotes are shown.
